60 Degrees Pharmaceuticals, Inc. (SXTP)
Largest Insider Buys in Sector
SXTP Stock Price History Chart
SXTP Stock Performance
About 60 Degrees Pharmaceuticals, Inc.
60 Degrees Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses …
Insider Activity of 60 Degrees Pharmaceuticals, Inc.
Over the last 12 months, insiders at 60 Degrees Pharmaceuticals, Inc. have bought $126,023 and sold $0 worth of 60 Degrees Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at 60 Degrees Pharmaceuticals, Inc. have bought $126,023 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: DOW GEOFFREY S (President and CEO) — $96,123. XU CHERYL (director) — $29,900.
The last purchase of 2,000 shares for transaction amount of $2,900 was made by XU CHERYL (director) on 2024‑12‑16.
List of Insider Buy and Sell Transactions, 60 Degrees Pharmaceuticals, Inc.
| 2024-12-16 | director | 2,000 0.0839% | $1.45 | $2,900 | -9.27% | |||
| 2024-12-13 | director | 6,000 0.2885% | $1.56 | $9,375 | +4.96% | |||
| 2024-12-12 | director | 5,000 0.2453% | $1.82 | $9,125 | -12.42% | |||
| 2024-12-09 | President and CEO | 35,823 1.437% | $1.27 | $45,563 | +4.14% | |||
| 2024-12-06 | President and CEO | 20,579 0.8725% | $1.20 | $24,672 | +30.00% | |||
| 2024-12-05 | President and CEO | 17,549 0.7539% | $1.11 | $19,520 | +24.37% | |||
| 2024-11-21 | President and CEO | 3,500 0.1312% | $0.91 | $3,195 | +35.01% | |||
| 2024-11-20 | President and CEO | 1,000 0.038% | $0.92 | $924 | +27.17% | |||
| 2024-11-19 | President and CEO | 2,500 0.0923% | $0.90 | $2,248 | +26.09% | |||
| 2024-08-27 | director | 5,000 0.349% | $1.70 | $8,500 | -35.71% |